Clinical trial
FIT3 : Exercise Timing for a Novel Treatment for Obesity
NCT05030636 is registered in ClinicalTrials.gov with Université de Montréal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FIT3 : Exercise Timing for a Novel Treatment for Obesity
- Lead sponsor
- Université de Montréal
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2021
- Completion date
- April 30, 2025
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exercise timing in obesity, obesity, adolescent